Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.

PHASE2CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

November 23, 2019

Study Completion Date

November 23, 2019

Conditions
Malaria
Interventions
DRUG

KAE609

Exploration of different doses of KAE609 to establish safety profile.

DRUG

Coartem

Control Arm

Trial Locations (9)

Unknown

Novartis Investigative Site, Lambaréné

Novartis Investigative Site, Kintampo

Novartis Investigative Site, Navrango

Novartis Investigative Site, Bamako

Novartis Investigative Site, Sotouba

Novartis Investigative Site, Kigali

Novartis Investigative Site, Bushenyi

Novartis Investigative Site, Kampala

Novartis Investigative Site, Tororo

Sponsors
All Listed Sponsors
collaborator

Wellcome Trust

OTHER

lead

Novartis Pharmaceuticals

INDUSTRY